Skip to NavigationSkip to content

PwC appoints Issy Corbett as healthcare M&A partner

Published on: 01/02/16

PwC has appointed Issy Corbett as a partner to lead its healthcare M&A team.

Corbett joins PwC from Rothschild, where he worked for ten years covering healthcare in the UK and continental Europe. During his time at Rothschild, Corbett worked on a number of completed transactions spanning M&A, IPO, sale and leaseback and refinancing.

In his new role, Issy will lead PwC's healthcare M&A team, based in London, and will work with colleagues across the firm including the international network, the UK regional offices, strategy, transaction services and public sector advisory.

Andrew McKechnie, partner and head of healthcare deals, says: “Issy's experience and reputation in healthcare M&A is market-leading. Together, our healthcare deals practice will offer clients a full suite of healthcare advisory services across a deal lifecycle.”

Issy Corbett adds “I am very excited and proud to join a firm of PwC's global reputation to reinforce its healthcare M&A business at what is such a vibrant time for the industry.”

Quentin Cole, health industries leader at PwC, says: “We are further investing across our health industries practice to ensure we have people with a depth of relevant experience that can be brought to bear in working with clients on solving the many complex and challenging issues facing the wider health economy.”

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches